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Background
Novel strategies are needed for the elicitation of broadly
neutralizing antibodies to HIV gp120. Experimental evi-
dence suggests that combinations of antibodies broadly
neutralizing in vitro may protect against challenge with
SHIV in nonhuman primates. A small number of these
antibodies have been selected by repertoire sampling of B
cells and by the fractionation of antiserum from some
patients. Yet no strategy for eliciting these antibodies or
additional broadly neutralizing antibodies has been suc-
cessful to date. We postulate that additional cryptic
epitopes of gp120 are present against which neutralizing
antibodies might be elicited, even though these antibod-
ies are not elicited by gp120, and that many of these
epitopes may be accessible to antibodies should they be
formed. If they are of sufficient affinity, some antibodies
against additional epitopes might be broadly neutralizing.
Methods
We demonstrate a novel strategy for eliciting antibodies in
mice against selected cryptic, conformationally dependent
conserved epitopes of gp120 by immunizing with Multi-
ple identical Copies of Peptides (MCPs) covalently linked
in branched structures using the α and ε amino groups of
lysine, representing conserved domains of gp120. This has
been achieved with MCPs representing 3 different
domains of gp120: (residues 105–117 α helix; 363–384
CD4 binding region; 426–441 or 419–439 β20β21 loop).
Results
Antibodies elicited by MCPs bind to native but not dena-
tured gp120, are not elicited by immunization with
gp120, and are not present in human HIV immunoglobu-
lin. Some antibodies bind to trimeric gp120 on cells
infected with multiple genotypes of HIV, bind to gp120
with relatively high affinity, and one of the monoclonal
antibodies has modest neutralizing activity. Binding of
antibodies to gp120 is blocked by incubation specific
MCPs. Once elicited, these antibodies can be used to
determine if the epitopes are accessible on native gp120.
Conclusion
MCPs can elicit antibodies to conserved cryptic conforma-
tional epitopes of gp120.
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